HeNan
HeNan
Zhengzhou, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma | Unresectable Biliary Tract Carcinoma | Recruiting | Phase 2 | 2024-12-27 | NCT06749730 |